Larson Financial Group LLC raised its stake in CME Group Inc. (NASDAQ:CME – Free Report) by 22.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,845 shares of the financial services provider’s stock after buying an additional 525 shares during the period. Larson Financial Group LLC’s holdings in CME Group were worth $661,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Lake Street Advisors Group LLC raised its holdings in CME Group by 108.7% during the fourth quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider’s stock worth $2,949,000 after purchasing an additional 6,453 shares during the last quarter. Meyer Handelman Co. acquired a new position in shares of CME Group during the 4th quarter worth $6,144,000. Spire Wealth Management boosted its position in shares of CME Group by 37.4% in the 4th quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider’s stock worth $307,000 after buying an additional 359 shares in the last quarter. AEGON ASSET MANAGEMENT UK Plc grew its stake in CME Group by 19.3% in the 4th quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider’s stock valued at $75,730,000 after acquiring an additional 52,862 shares during the last quarter. Finally, Bank of Montreal Can increased its holdings in CME Group by 41.8% during the 3rd quarter. Bank of Montreal Can now owns 1,028,090 shares of the financial services provider’s stock valued at $224,432,000 after acquiring an additional 303,169 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.
CME Group Trading Up 0.2 %
Shares of CME stock opened at $254.57 on Monday. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $258.78. The firm’s 50-day simple moving average is $240.07 and its 200-day simple moving average is $230.85. The firm has a market cap of $91.74 billion, a P/E ratio of 26.33, a PEG ratio of 6.76 and a beta of 0.53. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02.
CME Group announced that its Board of Directors has initiated a stock repurchase plan on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in shares. This repurchase authorization authorizes the financial services provider to repurchase up to 3.4% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s management believes its shares are undervalued.
CME Group Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Friday, March 7th will be issued a $1.25 dividend. The ex-dividend date is Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a yield of 1.96%. This is a boost from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio (DPR) is presently 51.71%.
Insider Buying and Selling at CME Group
In other CME Group news, insider Hilda Harris Piell sold 3,984 shares of CME Group stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total transaction of $997,872.48. Following the transaction, the insider now directly owns 27,046 shares of the company’s stock, valued at $6,774,211.62. The trade was a 12.84 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, COO Suzanne Sprague sold 1,500 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total transaction of $385,245.00. Following the completion of the sale, the chief operating officer now directly owns 8,036 shares of the company’s stock, valued at $2,063,885.88. The trade was a 15.73 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 17,076 shares of company stock valued at $4,271,496. Company insiders own 0.30% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts have issued reports on CME shares. JPMorgan Chase & Co. upped their price target on shares of CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a report on Thursday, February 13th. Oppenheimer upped their target price on CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a research note on Thursday, February 13th. Citigroup downgraded CME Group from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $255.00 to $250.00 in a research report on Monday, January 6th. Barclays upped their price objective on CME Group from $257.00 to $263.00 and gave the company an “equal weight” rating in a research report on Thursday, February 13th. Finally, Keefe, Bruyette & Woods lifted their price objective on CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a research report on Friday, February 14th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $235.50.
Get Our Latest Analysis on CME
CME Group Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- Manufacturing Stocks Investing
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- The Risks of Owning Bonds
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- What is the Dow Jones Industrial Average (DJIA)?
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.